Jesse Fishman

Associate Director)

Responsible for developing and leading health economic research and value demonstration activities to support assigned products within UCB's portfolio

Key Accomplishments:

• Developed successful product and Health Economics Outcomes Research (HEOR) studies evidence plans for a new product that optimized market access. Included development of unique economic story arch to differentiate a new molecule in a previously crowded generic market resulting in 5M increase on sales

• Designed, monitored, and implemented smart phone based adherence programs to improve patient outcomes which were included in value based contracts increasing commercial reimbursement by 5-10% of annual product sales

• Engaged in several collaborative research initiatives with health plans and integrated delivery networks providing data and tools for population based risk stratification for decision-makers to support cost effective disease state management and improved formulary position

• Created high impact payer tools that maintained or attained commercial coverage for millions of patients (eg Budget Impact Models, Cost Effectiveness Models)

• Managed the design and execution of numerous HEOR studies and associated publications resulting in field communication materials used with formulary decision makers

Responsible for developing and leading health economic research and value demonstration activities to support assigned products within UCB’s portfolio

Key Accomplishments:

• Developed successful product and Health Economics & Outcomes Research (HEOR) studies evidence plans for a new product that optimized market access. Included development of unique economic story arch to differentiate a new molecule in a previously crowded generic market resulting in 5M increase on sales
• Designed, monitored, and implemented smart phone based adherence programs to improve patient outcomes which were included in value based contracts increasing commercial reimbursement by 5-10% of annual product sales
• Engaged in several collaborative research initiatives with health plans and integrated delivery networks providing data and tools for population based risk stratification for decision-makers to support cost effective disease state management and improved formulary position
• Created high impact payer tools that maintained or attained commercial coverage for millions of patients (eg Budget Impact Models, Cost Effectiveness Models)
• Managed the design and execution of numerous HEOR studies and associated publications resulting in field communication materials used with formulary decision makers

Medical Affairs (Level: Sr Manager)

Responsible to lead strategy and execution of large and complex medical affairs research programs, responsible for strategy, project and resource allocation, and communication of program results to external community

Key Accomplishments:

• Led the implementation of new field insights gathering and action process resulting in 2 new research programs and improved KOL engagement

• Led development of medical symposiums at international meetings to support value proposition delivered to over 400 KOLs which improved their education of our products

• Delivered strategically aligned publications of Real World Outcomes Research data in partnership with HEOR/Medical leads that communicated the value of UCB products supporting their market access

• Created a position and a valuation methodology to support the sunshine acts reporting requirements including communication plan to epilepsy KOLs

• Lead a task force that developed/launched a company-wide volunteer program; responsibilities included development of all program materials and training which increased employee engagement by 3%

• Developed, trained, mentored 2 publication managers resulting in their promotion

Responsible to lead strategy and execution of large and complex medical affairs research programs, responsible for strategy, project and resource allocation, and communication of program results to external community

Key Accomplishments:

• Led the implementation of new field insights gathering and action process resulting in 2 new research programs and improved KOL engagement
• Led development of medical symposiums at international meetings to support value proposition delivered to over 400 KOLs which improved their education of our products
• Delivered strategically aligned publications of Real World & Outcomes Research data in partnership with HEOR/Medical leads that communicated the value of UCB products supporting their market access

• Created a position and a valuation methodology to support the sunshine acts reporting requirements including communication plan to epilepsy KOLs
• Lead a task force that developed/launched a company-wide volunteer program; responsibilities included development of all program materials and training which increased employee engagement by 3%
• Developed, trained, mentored 2 publication managers resulting in their promotion

(Level: Sr Manager)

Responsible for payer deliverable development such as market access slide kits, payer dossiers, government submissions

Key Accomplishments:

• Co-led the recruitment (n=8) and infrastructure development (eg SOP's, templates, guidance documents) of a payer center of excellence which maintained or attained coverage with US and international health plans for billion dollar products

• Lead a writing task force to support medical writing and evidence development of National Quality Measure (NQF #1666) Patients on Erythropoiesis Stimulating Agent (ESA)--Hemoglobin Level 12.0 g/dL used to establish a national clinical guideline

• Developed and completed a one year health economics rotation which involved completing 3 key projects overseen by the health economics director to support market access of Neulasta

• Managed, mentored, and trained: direct reports (n=2) and freelance writers (n=2) resulting in 1 promotion and 2 company awards for those employees

• Established relationship with opinion leaders to obtain, create, and update product messaging and to facilitate ongoing conduct of publications and other associated activities supporting product value proposition

Manager)

Responsible for development of medical communication information including medical information requests and letters, payer dossiers, and programs to improve patient outcomes

Key Accomplishments:

• Assisted with the development of the URAC platinum award winning multiple sclerosis disease therapy management program that improved education and support for patients to self-manage their symptoms and medication therapy

• Built a medical communications group in India which included recruitment, infrastructure development, and quality process which increased profit margins on deliverables by 25%

• Completed one year junior executive leadership program and was among 15 of 235 applicants selected

• Provided consulting support for specialty medications and consulted on complex conditions to offer personalized therapy to support and optimize health outcomes.

• Developed and wrote medical policies, drug policies, and coverage determination guidelines to assist us in administering health benefits, under supervision of the medical director

• Wrote and maintained formulary guidance related to drug coverage and drug tiers; Evaluated pharmaceutical drug submissions of AMCP dossiers to establish formulary positioning

Responsible for delivery of quality medical care in a complex and matrix environment

Key Accomplishments

• Led, developed, and completed six sigma analysis to reduce pharmacy dispensing errors; final recommendations resulted in 35% daily reduction of dispensing errors

• Developed a quarterly educational program for staff of 25 clinical pharmacists to obtain their CE. Involved content development, presentation of content, as well obtaining accreditation for the program

• Invited to speak at physician and pharmacy grand rounds on numerous occasions to physician audiences of 50-75

• Performed ward rounds with critical care teams to provide medication consultations, recommendations, and interventions resulting in excellent bedside care

• Ensured support for patients by ensuring adequate monitoring such as appropriate observation and physiological parameters. Interpreted pharmacokinetic data for critical care patients

Senior Associate)

Responsible for leading the medical information and communications department

Key Accomplishments:

• Assisted business development with a 6 month evaluation and acquisition of TWINJECT Epinephrine auto injector; included medical review of regulatory documents, market evaluation, and patent review resulting in an annual increase of 1 million dollar revenue.

• Developed managed care dossiers used by PT committees for formulary approval of 7 products with major health plans in the US

• Led development of Medicaid testimonies, CMS, and other government response documents supporting market access of 10 products

• Provided writing, editing, and revisions for global medical information letters via print and electronic media platforms (standard response documents, FAQ's, dossiers, websites)

Completed a 1 year health economics fellowship

4 year PharmD Program which included clinical training